Background. Complex aortic valve and root pathology presents a serious
operative challenge. Methods. During the last 45 months 21 cryopreser
ved homograft root replacements have been performed in 19 patients. Th
e ages of the patients ranged from 28 to 77 years; there were 15 men a
nd four women. Six patients had endocarditis, four prosthetic and two
native valve endocarditis. One patient underwent homograft aortic root
replacement twice; one underwent concomitant homograft right ventricu
lar outflow tract reconstruction for pulmonic endocarditis. Causes of
aortic pathology in the other 13 patients included ascending aortic an
eurysm with valvular regurgitation in seven, Marfan syndrome in two, a
nd four aortic dissections with aortic regurgitation. Ten of the ninet
een patients were undergoing reoperative procedures. Results. There we
re three hospital deaths and one death at home of unknown cause. Two o
f the three patients who died in hospital had undergone redo cardiac p
rocedures. Dramatic functional class improvement was seen in all survi
vors. Conclusions. Follow-up from 2 to 45 months in the fifteen surviv
ors revealed no clinical or significant echocardiographic evidence of
valvular regurgitation or recurrent infection. We believe homograft ro
ot replacement provides an excellent method of reconstruction with sev
eral advantages unique to human valved conduits, including ease of han
dling, lack of synthetic nidus for recurrent infection, and absence of
thrombogenic materials. Homografts should be considered the approach
of choice in complex valvular and root infectious processes.